Retatrutide GLP-3 is sold for laboratory, research, or analytical purposes only not for human consumption, veterinary use, or medical applications
Other compounds are also entering the picture
Your cart is empty Continue Shopping Order before 14:00 for same-day shipping Order within 00 hours 00 minutes Order before 14:00 for same-day shipping Order within 00 hours 00 minutes This research bundle brings together five vials of Retatrutide 20 mg a lyophilized triple-receptor agonist peptide with the consumables and storage accessories needed to support organised, efficient laboratory work
Unlike other approved GLP-1 medications, Wegovy and Zepbound, which also target the gut hormone GLP-1, retatrutide targets three receptors known to regulate appetiteGLP-1, glucagon and glucose-dependent insulinotropic polypeptide (GIP)
62.5% of participants lost at least 25% of their body weight
The most well-known GLP-1 receptor agonists include semaglutide (sold as Ozempic for diabetes and Wegovy for weight loss), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and exenatide (Byetta, Bydureon)